Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when PRVA files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: PRVA Privia Health Group, Inc. 8-K

Privia Health stockholders re-elect directors, approve executive pay at annual meeting

Filed May 22, 2026 · Period ending May 20, 2026 · ~1 min read

3 key changes

Key Changes

  • low

    Stockholders elected three Class I directors (Nancy Cocozza, David King, Francis Soistman) to serve three-year terms expiring in 2029, with all nominees receiving majority support.

  • low

    Executive compensation approved on advisory basis with 98% support (103.96M votes for vs. 1.81M against), indicating shareholder satisfaction with management pay practices.

  • low

    PricewaterhouseCoopers LLP ratified as independent auditor for fiscal 2026 with overwhelming approval (117.34M votes for), confirming continuity in external audit relationship.

Summary

Privia Health held its annual stockholder meeting on May 20, 2026, completing routine corporate governance matters. The company's stockholders re-elected three directors to the board, approved executive compensation on an advisory basis, and ratified the appointment of PwC as the company's auditor. All proposals passed with strong support, indicating general shareholder satisfaction with management and board oversight.

For retail investors, this filing represents standard annual meeting business with no material changes to company operations or strategy. The high approval rates across all proposals suggest alignment between management and shareholders. Watch for the company's proxy statement later this year, which will provide detailed compensation disclosures and any changes to board composition or governance practices heading into 2027.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · May 24, 2026 · How we verify